London, United Kingdom--(Newsfile Corp. - May 21, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, reported that it expects to implement a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on The Nasdaq Capital Market under the symbol "AKAN". The new CUSIP number for the ordinary shares following the ...

Akanda Announces Closing of Subsequent Registered Direct OfferingMay 20, 2024 1:27 PM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced second registered direct offering for the sale and issuance of 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded warrants to purchase 12,05 ...

Akanda Corp. Announces Subsequent Registered Direct OfferingMay 17, 2024 3:59 PM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a second securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded wa ...

Akanda Announces Closing of Registered Direct OfferingMay 17, 2024 3:40 PM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 2,491,381 common shares at a purchase price of $0.1031 per share, and 21,756,922 pre-funded warrants to purchase 21,756,922 ...

Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMay 17, 2024 10:26 AM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381 common shares at a purchase price of $0.1031 and ...

Akanda Corp (NASDAQ: AKAN) is in focus this morning after receiving a notice of non-compliance from Nasdaq. Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.Akanda fails to satisfy the Nasdaq listing requirementsCopy link to sectionThe deficiency notification was issued to the international medical cannabis company because it failed to meet the “minimum stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1).  $AKAN failed to sa ...

Akanda (NASDAQ:AKAN) stock is heading higher on Friday despite the cannabis company getting a non-compliance notice from the Nasdaq Exchange.The issue here is AKAN stock not meeting the minimum stockholders’ equity requirement to remain on the Nasdaq Exchange. This requires a minimum stockholders’ equity of $2.5 million. Akanda’s was -$3,828,892 in its latest filing.The Nasdaq Exchange is giving Akanda 45 calendar days, or until June 28, 2024, to submit a plan to regain compliance. If it does so, it may be ...

Akanda Corp. Receives Notice of Non-Compliance from NASDAQMay 16, 2024 3:28 PM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), announced that it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance with the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1).According to Nasdaq's listing ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares AKAN The Nasdaq Capital Market FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE S ...

Exhibit 99.1 Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) | As at | | | June 30, | | December 31, | | --- | --- | --- | --- | --- | --- | | | Note | | 2023 | | 2022 | | ASSETS | | | | | | | Current | | | | | | | Cash | | $ | 443,338 | $ | 228,794 | | Cash held in trust | | | — | | 27,009 | | Trade and other receivables | 6 | | 657,568 | | 1,235,619 | | Prepayments | | | 336,985 | | 199,488 | | Biological assets | 7 | | 257,144 | ...